Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation. Klein CJ, Triplett JD, Murray DL, Gorsh AP, et al. Neurology 2024;103:e210000.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Klein CJ, Triplett JD, Murray DL, Gorsh AP, et al. Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation. Neurology 2024;103:e210000.
PMID: 39499873